Pulmonx Corporation Cash on Hand 2019-2024 | LUNG
Pulmonx Corporation Annual Cash on Hand (Millions of US $) |
|
---|---|
2023 | $117 |
2022 | $141 |
2021 | $180 |
2020 | $232 |
2019 | $28 |
2018 | $4 |
Pulmonx Corporation Quarterly Cash on Hand (Millions of US $) |
|
---|---|
2024-09-30 | $108 |
2024-06-30 | $115 |
2024-03-31 | $116 |
2023-12-31 | $117 |
2023-09-30 | $117 |
2023-06-30 | $136 |
2023-03-31 | $153 |
2022-12-31 | $141 |
2022-09-30 | $157 |
2022-06-30 | $162 |
2022-03-31 | $170 |
2021-12-31 | $180 |
2021-09-30 | $200 |
2021-06-30 | $210 |
2021-03-31 | $219 |
2020-12-31 | $232 |
2020-09-30 | $40 |
2020-06-30 | |
2020-03-31 | |
2019-12-31 | |
2019-09-30 | |
2018-12-31 | $4 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. |